Adding fan-to-face therapy to a supervised exercise training program lowers exertional breathlessness across training ...
Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with the potential for best-in-class profiles in the largest inflammatory and ...
Sleep data captured with a wearable device could help clinicians better tailor care by identifying patients with chronic ...
Exercises that strengthen respiratory muscles in the chest can help improve lung function in people with multiple sclerosis, ...
Keymed Biosciences (HKEX: 02162) announced its 2025 annual results. The year marked the company's 10th anniversary and a pivotal year in its transition from R&D to commercialization.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results